colistimethate sodium has been researched along with Acute Symptom Flare in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilton, D; Caine, N; Charman, SC; Kaplan, S; Lee, A | 1 |
1 other study(ies) available for colistimethate sodium and Acute Symptom Flare
| Article | Year |
|---|---|
Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Colistin; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Registries; Respiratory Tract Infections; Symptom Flare Up; United Kingdom | 2021 |